-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in Refractory Acute Myeloid Leukemia Drug Details: RD13-02...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in Relapsed Acute Myeloid Leukemia Drug Details: RD13-02...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Sector Analysis
NewCanada Sports Broadcasting Media (Television and Telecommunications) Market Landscape
The Canada Media Landscape Report provides an overview of the television and telecommunications market in relation to sports broadcasting in Canada today, with top-level data and detailed forecasts of key indicators up to 2028. The report analyses the television, SVOD, mobile handset and residential fixed-line broadband sectors, as well as a review of major sports media rights.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in T-Cell Acute Lymphocytic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Insulin Degludec LA in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Degludec LA in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insulin Degludec LA in Type 2 Diabetes Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obexelimab in Acquired (Autoimmune) Hemolytic Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obexelimab in Acquired (Autoimmune) Hemolytic Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obexelimab in Acquired (Autoimmune) Hemolytic Anemia Drug Details: Obexelimab...
-
Sector Analysis
Automotive Steering Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Steering Systems Market Report Overview The steering systems market size was 91 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. Continuous advancements in technology, such as improvements in electric power steering (EPS), sensors, and control algorithms drive the innovation of steering systems. In 2023, Asia-Pacific accounted for a significant share of the automotive steering systems market. Automotive Steering Systems Market Outlook, 2023-2028 (Million Units) Buy the Full Report for More...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dupilumab in Grass Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Grass Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Grass Pollen Allergy Drug Details: Dupilumab (REGN-668, SAR231893, Dupixent,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dupilumab in Keloids
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Keloids report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Keloids Drug Details: Dupilumab (REGN-668, SAR231893, Dupixent, Dubrantis) is a...